NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $273,290 | +7.1% | 2,683 | +6.1% | 0.07% | +6.0% |
| Q2 2023 | $255,201 | +30.2% | 2,529 | +18.7% | 0.07% | +21.8% |
| Q1 2023 | $195,960 | +9.6% | 2,130 | +8.1% | 0.06% | +5.8% |
| Q4 2022 | $178,718 | +18.4% | 1,970 | -0.9% | 0.05% | +15.6% |
| Q3 2022 | $151,000 | +18.9% | 1,988 | +32.3% | 0.04% | +18.4% |
| Q2 2022 | $127,000 | +44.3% | 1,503 | +50.0% | 0.04% | +65.2% |
| Q1 2022 | $88,000 | +11.4% | 1,002 | +10.7% | 0.02% | +9.5% |
| Q4 2021 | $79,000 | +6.8% | 905 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $74,000 | -10.8% | 905 | 0.0% | 0.02% | -8.7% |
| Q2 2021 | $83,000 | +7.8% | 905 | 0.0% | 0.02% | +9.5% |
| Q1 2021 | $77,000 | -23.8% | 905 | -16.0% | 0.02% | -30.0% |
| Q4 2020 | $101,000 | +18.8% | 1,078 | 0.0% | 0.03% | +11.1% |
| Q3 2020 | $85,000 | – | 1,078 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |